Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00112372
Status:
COMPLETED
Last Update Posted:
2015-02-12
First Post:
2005-06-02
Brief Title:
Study of Oral Ridaforolimus AP23573 MK-8669 to Treat Patients With Refractory or Advanced Malignancies MK-8669-016 AM4COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-05
Start Date Type:
None
Primary Completion Date:
2008-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-03
Completion Date Type:
ACTUAL
First Submit Date:
2005-06-02
First Submit QC Date:
June 2 2005
Study First Post Date:
2005-06-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-02-11
Last Update Post Date:
2015-02-12
Last Update Post Date Type:
ESTIMATED